GLYCEMICON

Glycemicon AG is a Swiss biotechnology company developing novel nutraceuticals for managing prediabetes, diabetes and obesity, using new approaches that were initially developed at the University of Science & Technology ETH Zurich. The lead product’s active substance is a naturally-occurring bile acid, THBA, which drives changes to the body fat architecture that combat elevated blood glucose levels. Glycemicon stands for "glycemic control" - the maintenance of healthy blood sugar levels, which is the aim of every individual living with prediabetes and diabetes.

#People #Financial #Website #More

GLYCEMICON

Industry:

Biotechnology Nutraceutical

Founded:

2013-01-01

Address:

Brügg, Bern, Switzerland

Country:

Switzerland

Website Url:

http://www.glycemicon.com

Total Employee:

11+

Status:

Active

Contact:

+41 56 560 50 20

Email Addresses:

[email protected]

Total Funding:

5.16 M CHF

Technology used in webpage:

SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Nginx Amazon CloudFront OpenResty Google Adsense AWS Global Accelerator Smart App Banner